1
|
Zhang J, Liu X, Zhou X, Li Y, Chen K, Kang T, Du W, Suo R. The Relationship Between Benefit Finding and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease: The Mediating Effects of Self-Management. Int J Chron Obstruct Pulmon Dis 2024; 19:2011-2021. [PMID: 39291239 PMCID: PMC11407311 DOI: 10.2147/copd.s465953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Accepted: 08/12/2024] [Indexed: 09/19/2024] Open
Abstract
Objective To explore the relationships among benefit finding (BF), self-management, and quality of life (QOL) among patients with COPD. Methods A total of 205 patients with COPD were selected via a convenient sampling method. BF refers to the ability to find meaning or benefit from difficult situations. The Benefit Finding Scale (BFS), self-management scale, and 36-item Short-Form Health Survey (MOS SF-36) were used to investigate BF, self-management and QOL (including a physical component summary (PCS) and a psychological component summary (MCS)). Structural equation modeling was used to examine the relationships among BF, self-management and QOL in patients with COPD and to analyze the effects of BF and self-management on QOL. Results The total QOL score of patients with COPD was 61.38±21.15, and the PCS and MCS scores were 57.67±23.60 and 65.09±21.24, respectively. BF and self-management had positive predictive effects on both the PCS (βBF = 0.519, PBF = 0.012; βself-management = 0.473, Pself-management = 0.012) and MCS (βBF = 0.425, PBF = 0.013; βself-management = 0.535, Pself-management = 0.016) of patients with COPD, and self-management mediated the relationships of BF with the PCS (β = 0.144, P = 0.008) and MCS (β = 0.162, P = 0.007). Conclusion The QOL of patients with COPD needs to be improved, especially in terms of physical aspects. Helping COPD patients obtain better BF not only helps them improve their PCS and MCS directly but also indirectly through enhancing self-management to improve their PCS and MCS.
Collapse
Affiliation(s)
- Jiangping Zhang
- The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai City, Guangdong Province, People's Republic of China
| | - Xinran Liu
- The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai City, Guangdong Province, People's Republic of China
| | - Xiaorong Zhou
- The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai City, Guangdong Province, People's Republic of China
| | - Yumei Li
- The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai City, Guangdong Province, People's Republic of China
| | - Ke Chen
- The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai City, Guangdong Province, People's Republic of China
| | - Tingting Kang
- The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai City, Guangdong Province, People's Republic of China
| | - Wenting Du
- The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai City, Guangdong Province, People's Republic of China
| | - Rongfei Suo
- The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai City, Guangdong Province, People's Republic of China
| |
Collapse
|
2
|
Moraitis AM, Iacob E, Wong B, Beck SL, Echeverria C, Donaldson G, Mooney K. Pairing automated exercise coaching with patient-reported symptom monitoring: A way to nudge exercise uptake during cancer treatment? Support Care Cancer 2024; 32:258. [PMID: 38558321 DOI: 10.1007/s00520-024-08450-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Accepted: 03/19/2024] [Indexed: 04/04/2024]
Abstract
INTRODUCTION Symptoms during cancer treatment cause burden, diminished physical functioning, and poor quality of life. Exercise is recommended during treatment to mitigate symptoms; however, interventions are difficult to translate into clinical care due to the lack of patient uptake and clinical implementation barriers. We evaluated the uptake, acceptability, and impact of an automated ePRO exercise module triggered by three patient-reported symptoms: nausea/vomiting, fatigue, and anxiety, during chemotherapy. METHODS We conducted a secondary analysis of an exercise module intervention imbedded in the cancer symptom monitoring and management platform, Symptom Care at Home (SCH). Utilizing behavioral economics principles, the exercise module was triggered when any of the three symptoms were reported. Once triggered, participants were coached on exercise benefits for symptom reduction and then offered the opportunity to set weekly exercise goals plus tracking of the goal outcomes and receive further encouragement. We examined uptake, exercise goal setting and attainment, and symptom impact. RESULTS Of 180 SCH participants receiving the SCH intervention, 170 (94.4%) triggered the exercise module and 102 of the 170 (60%) accepted the module, setting goals on average for 6.3 weeks. Of 102 participants, 82 (80.4%) achieved one or more exercise goals, exercising on average 79.8 min/week. Participants who achieved a higher proportion of goals had statistically significant lower overall symptom severity and lower severity of the triggered symptom. CONCLUSION An automated mHealth exercise coaching intervention, aimed to nudge those receiving chemotherapy to initiate an exercise routine had significant uptake, is acceptable and may reduce symptom severity. TRIAL REGISTRATION NCT01973946.
Collapse
Affiliation(s)
- Ann Marie Moraitis
- Dana Farber Cancer Institute, Department of Pediatric Oncology, Boston, MA, USA.
| | - Eli Iacob
- College of Nursing, University of Utah, Salt Lake City, Utah, USA
| | - Bob Wong
- College of Nursing, University of Utah, Salt Lake City, Utah, USA
| | - Susan L Beck
- College of Nursing, University of Utah, Salt Lake City, Utah, USA
| | | | - Gary Donaldson
- Pain Research Center, Department of Anesthesiology, School of Medicine, University of Utah, Salt Lake City, Utah, USA
| | - Kathi Mooney
- College of Nursing, University of Utah, Salt Lake City, Utah, USA
| |
Collapse
|
3
|
Koç Z, Kaplan E, Tanrıverdi D. The effectiveness of telehealth programs on the mental health of women with breast cancer: A systematic review. J Telemed Telecare 2024; 30:405-419. [PMID: 35108131 DOI: 10.1177/1357633x211069663] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
Objective: The purpose of this systematic review is to determine the evidence-based information and results about the effectiveness of telehealth programs on the mental health of women with breast cancer. Methods: The research process was carried out using PRISMA guidelines. Randomized controlled trials with available abstract and full text, which were published in English with the keywords "telehealth," "telemedicine," "web-based therapy," "telepsychiatry," "online therapy" and "breast cancer" in Pub Med, PsycINFO, Medline, Science Direct, Scopus, Web of Sciences and Cochrane databases between 2015-2019 were searced. As a result of the evaluations, the research was completed with 16 studies meeting the research criteria. Results: There was strong evidence for reduce the fear of relapse of cancer, depressive symptoms and severity of depression, distress, intrusive thoughts, anxiety, sleep disorder, insomnia, improve quality of life and for improve cognitive functions, improve psychological strength and sleep quality of telehealth programs in women with breast cancer. Furthermore, evidence was found for increase psychological health, functionality, optimism and control over the future, positive mood and life appreciation, and drug compliance of these programs. Conclusion: This review found evidence for the effectiveness of telehealth programs on the mental problems of women with breast cancer. In this sense, it is recommended to expand the use of telehealth programs, which can save time and cost, are accessible and easily applicable by nurses, to improve the mental health of women with breast cancer, and further studies are recommended.
Collapse
Affiliation(s)
- Zeynep Koç
- Faculty of Health Sciences, Department of Nursing, Gaziantep University, Gaziantep, Turkey
| | - Ece Kaplan
- Faculty of Health Sciences, Department of Nursing, Gaziantep University, Gaziantep, Turkey
| | - Derya Tanrıverdi
- Faculty of Health Sciences, Department of Nursing, Gaziantep University, Gaziantep, Turkey
| |
Collapse
|
4
|
Kim SH, Sung JH, Yoo SH, Kim S, Lee K, Oh EG, Lee J. Effects of digital self-management symptom interventions on symptom outcomes in adult cancer patients: A systematic review and meta-analysis. Eur J Oncol Nurs 2023; 66:102404. [PMID: 37517339 DOI: 10.1016/j.ejon.2023.102404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2023] [Accepted: 07/22/2023] [Indexed: 08/01/2023]
Abstract
PURPOSE Digital self-management (SM) interventions targeting symptom relief have demonstrated positive as well as null outcomes, whereas no study has synthesized the effect of the interventions. In this study, we aimed to evaluate the effectiveness of digital SM symptom interventions on symptom outcomes in adult cancer patients. METHODS A systematic review and meta-analysis based on the previous scoping review was conducted. Six databases (PubMed, CINAHL, Embase, the Cochrane Library, RISS [Korean], and KoreaMed [Korean]) were searched. Population was adult cancer patients. Intervention was SM interventions applying digital health tool targeting symptom management. Comparison was usual care, waitlist controls or active controls. The primary outcome was symptom burden, and the secondary outcomes were individual symptoms. RESULTS Our meta-analysis of 32 randomized controlled trials (RCTs) including 7888 patients demonstrated that digital SM symptom interventions had a significant effect on reducing symptom burden (effect size [ES] = -0.230) and relieving pain (ES = -0.292), fatigue (ES = -0.417), anxiety (ES = -0.320), and depression (ES = -0.261). CONCLUSIONS Digital SM interventions can improve symptom outcomes in adult cancer patients. Oncology nurses should be aware that digital SM interventions have demonstrated promising outcomes in cancer patient care.
Collapse
Affiliation(s)
- Soo Hyun Kim
- Department of Nursing, Inha University, Incheon, South Korea
| | - Ji Hyun Sung
- College of Nursing, Kosin University, Busan, South Korea
| | - Sung-Hee Yoo
- College of Nursing, Chonnam National University, Gwangju, South Korea
| | - Sanghee Kim
- College of Nursing and Mo-im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Center of Korea, Joanna Briggs Institution, Yonsei University, Seoul, South Korea
| | - Kyunghwa Lee
- College of Nursing, Konyang University, Daejeon, South Korea
| | - Eui Geum Oh
- College of Nursing and Mo-im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Center of Korea, Joanna Briggs Institution, Yonsei University, Seoul, South Korea
| | - Jiyeon Lee
- College of Nursing and Mo-im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Center of Korea, Joanna Briggs Institution, Yonsei University, Seoul, South Korea.
| |
Collapse
|
5
|
An HJ, Kang SJ, Choi GE. Technology-based self-management interventions for women with breast cancer: a systematic review. KOREAN JOURNAL OF WOMEN HEALTH NURSING 2023; 29:160-178. [PMID: 37813660 PMCID: PMC10565530 DOI: 10.4069/kjwhn.2023.09.07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Revised: 09/01/2023] [Accepted: 09/07/2023] [Indexed: 10/11/2023] Open
Abstract
PURPOSE Since technology-based interventions can facilitate convenient access to healthcare for women with breast cancer, it is crucial to understand innovative approaches to maintaining the effectiveness of these interventions. Therefore, we conducted a systematic review of technology-based self-management interventions for women with breast cancer in six countries. We analyzed the characteristics of these interventions and examined their diverse health outcomes. METHODS Six databases were systematically searched to extract research articles using the keywords "breast cancer," "technology," and "self-management." The search was carried out up until June 12, 2023. From the 1,288 studies retrieved from the database search, 10 eligible papers were identified based on inclusion/exclusion criteria. Two authors independently extracted and compared the data from these articles, resolving any discrepancies through discussion. RESULTS Most of the 10 studies utilized web- or mobile-based technology, and one used artificial intelligence-based technology. Among the 12 health-related outcome variables, quality of life and symptom distress were the most frequently mentioned, appearing in six articles. Furthermore, an analysis of the intervention programs revealed a variety of common constructs and the involvement of managers in the self-management intervention. CONCLUSION Incorporating key components such as self-management planning, diary keeping, and communication support in technology-based interventions could significantly improve the self-management process for breast cancer survivors. The practical application of technology has the potential to empower women diagnosed with breast cancer and improve their overall quality of life, by providing timely and sustainable interventions, and by leveraging available resources and tools.
Collapse
|
6
|
Cox-Martin E, Phimphasone-Brady P, Hoffecker L, Glasgow RE. Psychosocial Interventions for Pain Management in Breast Cancer Survivors: A RE-AIM Evaluation. J Clin Psychol Med Settings 2023; 30:182-196. [PMID: 35562602 DOI: 10.1007/s10880-022-09874-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/10/2022] [Indexed: 12/24/2022]
Abstract
Psychosocial interventions for breast-cancer-related pain are effective, yet over 45% of survivors continue to struggle with this often-chronic side effect. This study evaluated multilevel indicators that can influence successful translation of interventions into clinical practice. The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework was applied to evaluate reporting of individual and setting/staff-level intervention indicators. A systematic search and multi-step screening process identified 31 randomized controlled trials for psychosocial interventions for breast cancer-related pain. Average reporting of indicators for individual-level dimensions (Reach and Effectiveness) were 65.2% and 62.3%, respectively. Comparatively, indicators for setting/staff-level dimensions were reported at a lower average frequency (Implementation, 46.8%; Adoption, 15.2%; Maintenance, 7.7%). Low reporting of setting/staff-level dimensions suggests gaps in the sustained implementation of psychosocial interventions. Implementation science methods and frameworks could improve trial design and accelerate the translation of psychosocial interventions for breast cancer-related pain into clinical practice.
Collapse
Affiliation(s)
- Emily Cox-Martin
- VA Puget Sound Health Care System, 9600 Veterans Dr SW, Tacoma, WA, 98493, USA.
| | | | - Lilian Hoffecker
- Strauss Health Sciences Library, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA
| | - Russell E Glasgow
- Department of Family Medicine, and ACCORDS Center, University of Colorado School of Medicine, Aurora, CO, USA
| |
Collapse
|
7
|
Chen W, Huang J, Cui Z, Wang L, Dong L, Ying W, Zhang Y. The efficacy of telemedicine for pain management in patients with cancer: a systematic review and meta-analysis. Ther Adv Chronic Dis 2023; 14:20406223231153097. [PMID: 36815091 PMCID: PMC9940183 DOI: 10.1177/20406223231153097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 01/10/2023] [Indexed: 02/19/2023] Open
Abstract
Background Pain is the most common cancer-related symptom, but it is often undertreated. Telemedicine is widely used in cancer treatment, but its effectiveness is uncertain. Objective We aimed to evaluate the impact of telemedicine intervention on pain in patients with cancer. Design Methodological quality and risk-of-bias evaluation were conducted, and the sources of heterogeneity were explored through subgroup analysis and sensitivity analysis. Data Sources and Methods PubMed, Embase, Web of Science, Cochrane Library, and clinical trial databases were searched up to 16 August 2022. Randomized controlled trials of the impact of telemedicine intervention regarding pain in patients with cancer were included, and the results related to pain were extracted. Results Twenty-one randomized controlled trials were selected from 1810 articles. A total of 1454 patients received telemedicine interventions, and 2213 received conventional medical services. Telemedical intervention had a positive effect on improving pain intensity [standard mean deviation (SMD) = -0.28, 95% confidence interval (CI): -0.49 to -0.06, p = 0.01] and pain interference (SMD = -0.41, 95% CI: -0.54 to -0.28, p < 0.00001), with statistical difference between the two groups. The subgroup analysis results showed that the telemedicine subgroup based on an application (SMD = -0.54, 95% CI: -0.91 to -0.18, p = 0.004) and the subgroup with intervention time ⩾ 6 months (SMD = -0.33, 95% CI: -0.52 to -0.13, p = 0.001), both demonstrated significant improvement regarding pain intensity, with significant statistical difference between the two groups. When the follow-up time was ⩾ 6 months, there was no significant difference (SMD = -0.24, 95% CI: -0.55 to 0.07, p = 0.13). Conclusion Compared with conventional medical services, telemedicine intervention can improve the pain of patients with cancer and is effective and acceptable regarding symptom monitoring. Integrating telemedicine interventions into cancer pain management may be a feasible option. But its long-term effects still need to be confirmed with more high-quality randomized controlled trials in the future. Registration https://www.crd.york.ac.uk/PROSPERO/; CRD42022361990.
Collapse
Affiliation(s)
| | | | | | - Lei Wang
- Department of General Medicine, Affiliated Hospital of Jiaxing University, Jiaxing, China
| | - Liang Dong
- Department of Information, Affiliated Hospital of Jiaxing University, Jiaxing, China
| | - Weifeng Ying
- Department of Information, Affiliated Hospital of Jiaxing University, Jiaxing, China
| | | |
Collapse
|
8
|
De Ravin E, Armache M, Campbell F, Rising KL, Worster B, Handley NR, Fundakowski CE, Cognetti DM, Mady LJ. Feasibility and Cost of Telehealth Head and Neck Cancer Survivorship Care: A Systematic Review. Otolaryngol Head Neck Surg 2023; 168:1312-1323. [PMID: 36939546 DOI: 10.1002/ohn.213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Revised: 10/28/2022] [Accepted: 11/12/2022] [Indexed: 01/30/2023]
Abstract
OBJECTIVE Evaluate the feasibility and cost-effectiveness of telehealth head and neck cancer (HNC) survivorship care. DATA SOURCES Ovid MEDLINE, Embase, Scopus, CINAHL. REVIEW METHODS A systematic search for peer-reviewed feasibility studies on telehealth models for HNC survivorship care published between 2005 and 2021 was conducted using the terms "head and neck cancer" and "telehealth" and their synonyms. Inclusion criteria were studies on telehealth survivorship program interventions for HNC patients with quantitative feasibility outcome measures (eg, enrollment, retention, attrition/dropout rate, adherence/task completion rate, patient satisfaction, cost). RESULTS Thirty-eight studies out of 1557 identified met inclusion criteria and were included for analysis. Feasibility outcomes evaluated were enrollment and attrition rates, adherence/task completion rates, patient satisfaction, and user feedback surveys in different survivorship domains. Patient enrollment ranged from 20.8% to 85.7%, while attrition ranged from 7% to 47.7%. Overall, adherence was 30.2% higher in the intervention group than in the control group (46.8% vs 16.6%). Studies with cost analysis found telehealth models of care to be statistically significantly less expensive and more cost-efficient than the standard model of care, with a $642.30 saving per patient (n = 3). Telehealth models also substantially reduced work time saving per visit (on average, 7 days per visit). CONCLUSION While telehealth survivorship programs are feasible and cost-effective and are associated with improved patient outcomes, they might not be ideal for every patient. Further investigations are needed to understand the role of telehealth in survivorship care, given the variability in study design, reporting, measures, and methodological quality.
Collapse
Affiliation(s)
- Emma De Ravin
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.,Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Maria Armache
- Department of Otolaryngology-Head and Neck Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Frank Campbell
- Penn Libraries, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Kristin L Rising
- Jefferson Center for Connected Care, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.,Department of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Brooke Worster
- Department of Hospice and Palliative Care, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Nathan R Handley
- Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Christopher E Fundakowski
- Department of Otolaryngology-Head and Neck Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - David M Cognetti
- Department of Otolaryngology-Head and Neck Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Leila J Mady
- Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| |
Collapse
|
9
|
Kukafka R, Kim S, Kim SH, Yoo SH, Sung JH, Oh EG, Kim N, Lee J. Digital Health Interventions for Adult Patients With Cancer Evaluated in Randomized Controlled Trials: Scoping Review. J Med Internet Res 2023; 25:e38333. [PMID: 36607712 PMCID: PMC9862347 DOI: 10.2196/38333] [Citation(s) in RCA: 12] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2022] [Revised: 09/15/2022] [Accepted: 10/25/2022] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND Digital care has become an essential component of health care. Interventions for patients with cancer need to be effective and safe, and digital health interventions must adhere to the same requirements. OBJECTIVE The purpose of this study was to identify currently available digital health interventions developed and evaluated in randomized controlled trials (RCTs) targeting adult patients with cancer. METHODS A scoping review using the JBI methodology was conducted. The participants were adult patients with cancer, and the concept was digital health interventions. The context was open, and sources were limited to RCT effectiveness studies. The PubMed, CINAHL, Embase, Cochrane Library, Research Information Sharing Service, and KoreaMed databases were searched. Data were extracted and analyzed to achieve summarized results about the participants, types, functions, and outcomes of digital health interventions. RESULTS A total of 231 studies were reviewed. Digital health interventions were used mostly at home (187/231, 81%), and the web-based intervention was the most frequently used intervention modality (116/231, 50.2%). Interventions consisting of multiple functional components were most frequently identified (69/231, 29.9%), followed by those with the self-manage function (67/231, 29%). Web-based interventions targeting symptoms with the self-manage and multiple functions and web-based interventions to treat cognitive function and fear of cancer recurrence consistently achieved positive outcomes. More studies supported the positive effects of web-based interventions to inform decision-making and knowledge. The effectiveness of digital health interventions targeting anxiety, depression, distress, fatigue, health-related quality of life or quality of life, pain, physical activity, and sleep was subject to their type and function. A relatively small number of digital health interventions specifically targeted older adults (6/231, 2.6%) or patients with advanced or metastatic cancer (22/231, 9.5%). CONCLUSIONS This scoping review summarized digital health interventions developed and evaluated in RCTs involving adult patients with cancer. Systematic reviews of the identified digital interventions are strongly recommended to integrate digital health interventions into clinical practice. The identified gaps in digital health interventions for cancer care need to be reflected in future digital health research.
Collapse
Affiliation(s)
| | - Sanghee Kim
- College of Nursing and Mo-im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Center of Korea: Affiliation of the Joanna Briggs Institution, Yonsei University, Seoul, Republic of Korea
| | - Soo Hyun Kim
- Department of Nursing, Inha University, Inchon, Republic of Korea
| | - Sung-Hee Yoo
- College of Nursing, Chonnam National University, Gwangju, Republic of Korea
| | - Ji Hyun Sung
- College of Nursing, Kosin University, Busan, Republic of Korea
| | - Eui Geum Oh
- College of Nursing and Mo-im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Center of Korea: Affiliation of the Joanna Briggs Institution, Yonsei University, Seoul, Republic of Korea
| | - Nawon Kim
- Yonsei Medical Library, Yonsei University, Seoul, Republic of Korea
| | - Jiyeon Lee
- College of Nursing and Mo-im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Center of Korea: Affiliation of the Joanna Briggs Institution, Yonsei University, Seoul, Republic of Korea
| |
Collapse
|
10
|
Singleton AC, Raeside R, Hyun KK, Partridge SR, Di Tanna GL, Hafiz N, Tu Q, Tat-Ko J, Sum SCM, Sherman KA, Elder E, Redfern J. Reply to M. Lv et al. J Clin Oncol 2023; 41:144-145. [PMID: 36122319 DOI: 10.1200/jco.22.01571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Affiliation(s)
- Anna C Singleton
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Rebecca Raeside
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Karice K Hyun
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Stephanie R Partridge
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Gian Luca Di Tanna
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Nashid Hafiz
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Qiang Tu
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Justin Tat-Ko
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Stephanie Che Mun Sum
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Kerry A Sherman
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Elisabeth Elder
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| | - Julie Redfern
- Anna C. Singleton, PhD, and Rebecca Raeside, MPH, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Karice K. Hyun, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Department of Cardiology, Concord Repatriation General Hospital, ANZAC Research Institute, New South Wales, Australia; Stephanie R. Partridge, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, Prevention Research Collaboration, Charles Perkins Center, The University of Sydney, New South Wales, Australia; Gian Luca Di Tanna, PhD, The George Institute for Global Health, University of NSW, New South Wales, Australia; Nashid Hafiz, MIPH, Qiang Tu, PhD, Justin Tat-Ko, BMSc, and Stephanie Che Mun Sum, BMSc, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia; Kerry A. Sherman, PhD, Department of Psychology, Center for Emotional Health, Macquarie University, New South Wales, Australia; Elisabeth Elder, PhD, Westmead Breast Cancer Institute, Westmead Hospital, New South Wales, Australia; and Julie Redfern, PhD, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, New South Wales, Australia, The George Institute for Global Health, University of NSW, New South Wales, Australia
| |
Collapse
|
11
|
Lv M, Luo X, Chen Y. Systematic Review on Electronic Health Interventions for Patients With Breast Cancer: Revisiting the Methodology. J Clin Oncol 2023; 41:143-144. [PMID: 36122308 DOI: 10.1200/jco.22.01061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Affiliation(s)
- Meng Lv
- Meng Lv, PhD candidate, Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China, Chongqing Key Laboratory of Pediatrics, Chongqing, China; Xufei Luo, MPH, School of Public Health, Lanzhou University, Lanzhou, China; and Yaolong Chen, MD, PhD, Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China, Chongqing Key Laboratory of Pediatrics, Chongqing, China, Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
| | - Xufei Luo
- Meng Lv, PhD candidate, Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China, Chongqing Key Laboratory of Pediatrics, Chongqing, China; Xufei Luo, MPH, School of Public Health, Lanzhou University, Lanzhou, China; and Yaolong Chen, MD, PhD, Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China, Chongqing Key Laboratory of Pediatrics, Chongqing, China, Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
| | - Yaolong Chen
- Meng Lv, PhD candidate, Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China, Chongqing Key Laboratory of Pediatrics, Chongqing, China; Xufei Luo, MPH, School of Public Health, Lanzhou University, Lanzhou, China; and Yaolong Chen, MD, PhD, Chevidence Lab of Child and Adolescent Health, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China, Chongqing Key Laboratory of Pediatrics, Chongqing, China, Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
| |
Collapse
|
12
|
Vaz-Luis I, Masiero M, Cavaletti G, Cervantes A, Chlebowski RT, Curigliano G, Felip E, Ferreira AR, Ganz PA, Hegarty J, Jeon J, Johansen C, Joly F, Jordan K, Koczwara B, Lagergren P, Lambertini M, Lenihan D, Linardou H, Loprinzi C, Partridge AH, Rauh S, Steindorf K, van der Graaf W, van de Poll-Franse L, Pentheroudakis G, Peters S, Pravettoni G. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. Ann Oncol 2022; 33:1119-1133. [PMID: 35963481 DOI: 10.1016/j.annonc.2022.07.1941] [Citation(s) in RCA: 55] [Impact Index Per Article: 27.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Revised: 07/26/2022] [Accepted: 07/29/2022] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND The increased number of cancer survivors and the recognition of physical and psychosocial challenges, present from cancer diagnosis through active treatment and beyond, led to the discipline of cancer survivorship. DESIGN AND METHODS Herein, we reflected on the different components of survivorship care, existing models and priorities, in order to facilitate the promotion of high-quality European survivorship care and research. RESULTS We identified five main components of survivorship care: (i) physical effects of cancer and chronic medical conditions; (ii) psychological effects of cancer; (iii) social, work and financial effects of cancer; (iv) surveillance for recurrences and second cancers; and (v) cancer prevention and overall health and well-being promotion. Survivorship care can be delivered by structured care models including but not limited to shared models integrating primary care and oncology services. The choice of the care model to be implemented has to be adapted to local realities. High-quality care should be expedited by the generation of: (i) focused and shared European recommendations, (ii) creation of tools to facilitate implementation of coordinated care and (iii) survivorship educational programs for health care teams and patients. The research agenda should be defined with the participation of health care providers, researchers, policy makers, patients and caregivers. The following patient-centered survivorship research areas were highlighted: (i) generation of a big data platform to collect long-term real-world data in survivors and healthy controls to (a) understand the resources, needs and preferences of patients with cancer, and (b) understand biological determinants of survivorship issues, and (ii) develop innovative effective interventions focused on the main components of survivorship care. CONCLUSIONS The European Society for Medical Oncology (ESMO) can actively contribute in the efforts of the oncology community toward (a) promoting the development of high-quality survivorship care programs, (b) providing educational material and (c) aiding groundbreaking research by reflecting on priorities and by supporting research networking.
Collapse
Affiliation(s)
- I Vaz-Luis
- Breast Cancer Unit, Medical Oncology Department, Gustave Roussy-Cancer Campus, Villejuif; UMR 981, Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy-Cancer Campus, Villejuif, France.
| | - M Masiero
- Department of Oncology and Hemato-Oncology, University of Milano, Milan; Applied Research Division for Cognitive and Psychological Science, Istituto Europeo di Oncologia, Milan
| | - G Cavaletti
- Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
| | - A Cervantes
- Department of Medical Oncology, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | | | - G Curigliano
- Department of Oncology and Hemato-Oncology, University of Milano, Milan; Division of Early Drug Development, Istituto Europeo di Oncologia, IRCCS, Milan, Italy
| | - E Felip
- Vall d'Hebron University Hospital, Barcelona, Spain
| | - A R Ferreira
- Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon; Catolica Medical School, Universidade Católica Portuguesa, Lisbon, Portugal
| | - P A Ganz
- UCLA Jonsson Comprehensive Cancer Center and UCLA Fielding School of Public Health, Los Angeles, USA
| | - J Hegarty
- School of Nursing and Midwifery, University College Cork, Cork, Ireland
| | - J Jeon
- Exercise Medicine Center for Cancer and Diabetes Patients (ICONS), Department of Sport Industry, Cancer Prevention Center, Yonsei Cancer Center, Shinchon Severance Hospital, Yonsei University College of Medicine, Yonsei University, Seoul, Korea
| | - C Johansen
- Centre for Cancer Late Effect Research (CASTLE), Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - F Joly
- Department of Medical Oncology, Centre François Baclesse, U1086 Anticipe, Unicaen Normandy Universtity, Caen, France
| | - K Jordan
- Department for Hematology, Oncology and Palliative Medicine, Ernst von Bergmann Hospital, Potsdam; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany
| | - B Koczwara
- Flinders Medical Centre and Flinders University, Adelaide, Australia
| | - P Lagergren
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Surgery and Cancer, Imperial College London, London, UK
| | - M Lambertini
- Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy
| | - D Lenihan
- International Cardio-Oncology Society, Tampa, USA
| | - H Linardou
- Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece
| | | | - A H Partridge
- Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
| | - S Rauh
- Department of Medical Oncology, Centre Hospitalier Emile Mayrisch, Esch, Luxembourg
| | - K Steindorf
- Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
| | - W van der Graaf
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam; Department of Medical Oncology, Erasmus MC Cancer institute, Erasmus University Medical Center, Rotterdam
| | - L van de Poll-Franse
- Division of Psychosocial Research & Epidemiology, Department of Psycological Research, The Netherlands Cancer Institute, Amsterdam; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht; CoRPS-Center of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands
| | - G Pentheroudakis
- European Society for Medical Oncology (ESMO), Lugano, Switzerland
| | - S Peters
- European Society for Medical Oncology (ESMO), Lugano, Switzerland
| | - G Pravettoni
- Department of Oncology and Hemato-Oncology, University of Milano, Milan; Applied Research Division for Cognitive and Psychological Science, Istituto Europeo di Oncologia, Milan
| |
Collapse
|
13
|
Beenhakker L, Witteveen A, Wijlens KAE, Siemerink EJM, van der Lee ML, Bode C, Siesling S, Vollenbroek‐Hutten MMR. Patient preference attributes in eHealth interventions for cancer-related fatigue: A scoping review. Eur J Cancer Care (Engl) 2022; 31:e13754. [PMID: 36385440 PMCID: PMC9786794 DOI: 10.1111/ecc.13754] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2022] [Revised: 10/05/2022] [Accepted: 10/09/2022] [Indexed: 11/18/2022]
Abstract
INTRODUCTION Cancer-related fatigue (CRF) is one of the most reported long-term effects breast cancer patients experience after diagnosis. Many interventions for CRF are effective, however, not for every individual. Therefore, intervention advice should be adjusted to patients' preferences and characteristics. Our aim was to develop an overview of eHealth interventions and their (preference sensitive) attributes. METHODS eHealth interventions were identified using a scoping review approach. Eligible studies included breast cancer patients and assessed CRF as outcome. Interventions were categorised as physical activity, mind-body, psychological, 'other' or 'combination'. Information was extracted on various (preference sensitive) attributes, like duration, intensity, peer support and costs. RESULTS Thirty-five interventions were included and divided over the intervention categories. (Preference sensitive) attributes varied both within and between these categories. Duration varied from 4 weeks to 6 months, intensity from daily to own pace. Peer support was present in seven interventions and costs were known for six. CONCLUSION eHealth interventions exist in various categories, additionally, there is much variation in (preference sensitive) attributes. This provides opportunities to implement our overview for personalised treatment recommendations for breast cancer patients struggling with CRF. Taking into account patients' preferences and characteristics suits the complexity of CRF and heterogeneity of patients.
Collapse
Affiliation(s)
- Lian Beenhakker
- Department of Biomedical Signals and SystemsUniversity of TwenteEnschedeThe Netherlands
| | - Annemieke Witteveen
- Department of Biomedical Signals and SystemsUniversity of TwenteEnschedeThe Netherlands
| | - Kim A. E. Wijlens
- Department of Biomedical Signals and SystemsUniversity of TwenteEnschedeThe Netherlands
| | | | - Marije L. van der Lee
- Scientific Research DepartmentHelen Dowling InstituteBilthovenThe Netherlands,Department of Medical and Clinical Psychology, Center of Research on Psychology in Somatic diseasesTilburg UniversityTilburgThe Netherlands
| | - Christina Bode
- Department of Psychology, Health and TechnologyUniversity of TwenteEnschedeThe Netherlands
| | - Sabine Siesling
- Department of Health Technology and Services Research, Technical Medical CentreUniversity of TwenteEnschedeThe Netherlands,Department of Research and DevelopmentNetherlands Comprehensive Cancer Organisation (IKNL)UtrechtThe Netherlands
| | - Miriam M. R. Vollenbroek‐Hutten
- Department of Biomedical Signals and SystemsUniversity of TwenteEnschedeThe Netherlands,Board of DirectorsMedisch Spectrum TwenteEnschedeThe Netherlands
| |
Collapse
|
14
|
Pinto M, Calafiore D, Piccirillo MC, Costa M, Taskiran OO, de Sire A. Breast Cancer Survivorship: the Role of Rehabilitation According to the International Classification of Functioning Disability and Health-a Scoping Review. Curr Oncol Rep 2022; 24:1163-1175. [PMID: 35403973 PMCID: PMC9467947 DOI: 10.1007/s11912-022-01262-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/08/2022] [Indexed: 12/20/2022]
Abstract
PURPOSE OF REVIEW The population of breast cancer (BC) survivors is growing due to earlier diagnosis and effective combined treatments. A scoping review was performed to explore the role of rehabilitation in BC survivorship and the major issues in BC survivors with International Classification of Functioning Disability and Health (ICF) perspective. RECENT FINDINGS The authors searched PubMed from January 1, 2018, up until November 9, 2021. The 65 selected publications were analyzed with the Comprehensive ICF BC Core Set (CCS) perspective and assigned to the categories of the CCS components along with the 3 areas of health (physical, mental, and social health). The multidimensional aspects of BC survivor disability are evident, whereas the topics of the articles concern several categories of the ICF BC CCS and all 3 areas of health. However, the current ICF BC CCS does not include certain categories related to emerging issues of BC survivorship recurring in the papers. Rehabilitation is crucial in BC survivorship management to give personalized answers to women beyond BC, and the ICF BC CCS remains an essential tool in rehabilitation assessment for BC survivors although it needs updating.
Collapse
Affiliation(s)
- Monica Pinto
- Rehabilitation Medicine Unit, Strategic Health Services Department, Istituto Nazionale Tumori -IRCCS - Fondazione G. Pascale, Naples, Italy
| | - Dario Calafiore
- Physical Medicine and Rehabilitation Unit, Department of Neurosciences, ASST Carlo Poma, Mantova, Italy
| | - Maria Carmela Piccirillo
- Clinical Trials Unit, Translational Research Department, Istituto Nazionale Tumori - IRCCS – Fondazione G. Pascale, Naples, Italy
| | - Massimo Costa
- Rehabilitation Medicine Unit, Department of Polyspecialistic Medicine, Cardarelli Hospital, Naples, Italy
| | - Ozden Ozyemisci Taskiran
- Department of Physical Medicine and Rehabilitation, Koç University School of Medicine, Istanbul, Turkey
| | - Alessandro de Sire
- Department of Medical and Surgical Sciences, Physical Medicine and Rehabilitation, University of Catanzaro “Magna Graecia,” Catanzaro, Catanzaro, Italy
| |
Collapse
|
15
|
Masiero MA, Filipponi C, Pizzoli SFM, Munzone E, Guido L, Guardamagna VA, Marceglia S, Caruso A, Prandin R, Prenassi M, Manzelli V, Savino C, Conti C, Rizzi F, Casalino A, Candiani G, Memini F, Chiveri L, Vitali AL, Corbo M, Milani A, Grasso R, Traversoni S, Fragale E, Didier F, Pravettoni G. “Usability testing of a new digital integrated health ecosystem PainRELife for the clinical man-agement of chronic pain in early breast cancer patients: Protocol for a Pilot Study” (Preprint). JMIR Res Protoc 2022; 12:e41216. [PMID: 37171843 DOI: 10.2196/41216] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2022] [Revised: 01/18/2023] [Accepted: 03/08/2023] [Indexed: 03/11/2023] Open
Abstract
BACKGROUND Chronic pain (CP) and its management are critical issues in the care pathway of patients with breast cancer. Considering the complexity of CP experience in cancer, the international scientific community has advocated identifying cutting-edge approaches for CP management. Recent advances in the field of health technology enable the adoption of a novel approach to care management by developing integrated ecosystems and mobile health apps. OBJECTIVE The primary end point of this pilot study is to evaluate patients' usability experience at 3 months of a new digital and integrated technological ecosystem, PainRELife, for CP in a sample of patients with breast cancer. The PainRELife ecosystem is composed of 3 main technological assets integrated into a single digital ecosystem: Fast Healthcare Interoperability Resources-based cloud platform (Nu platform) that enables care pathway definition and data collection; a big data infrastructure connected to the Fast Healthcare Interoperability Resources server that analyzes data and implements dynamic dashboards for aggregate data visualization; and an ecosystem of personalized applications for patient-reported outcomes collection, digital delivery of interventions and tailored information, and decision support of patients and caregivers (PainRELife app). METHODS This is an observational, prospective pilot study. Twenty patients with early breast cancer and chronic pain will be enrolled at the European Institute of Oncology at the Division of Medical Senology and the Division of Pain Therapy and Palliative Care. Each patient will use the PainRELife mobile app for 3 months, during which data extracted from the questionnaires will be sent to the Nu Platform that health care professionals will manage. This pilot study is nested in a large-scale project named "PainRELife," which aims to develop a cloud technology platform to interoperate with institutional systems and patients' devices to collect integrated health care data. The study received approval from the Ethical Committee of the European Cancer Institute in December 2021 (number R1597/21-IEO 1701). RESULTS The recruitment process started in May 2022 and ended in October 2022. CONCLUSIONS The new integrated technological ecosystems might be considered an encouraging affordance to enhance a patient-centered approach to managing patients with cancer. This pilot study will inform about which features the health technological ecosystems should have to be used by cancer patients to manage CP. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) DERR1-10.2196/41216.
Collapse
|
16
|
Bäuerle A, Martus P, Erim Y, Schug C, Heinen J, Krakowczyk JB, Steinbach J, Damerau M, Bethge W, Dinkel A, Dries S, Mehnert-Theuerkauf A, Neumann A, Schadendorf D, Tewes M, Wiltink J, Wünsch A, Zipfel S, Graf J, Teufel M. Web-based mindfulness and skills-based distress reduction for patients with cancer: study protocol of the multicentre, randomised, controlled confirmatory intervention trial Reduct. BMJ Open 2022; 12:e056973. [PMID: 35649607 PMCID: PMC9161102 DOI: 10.1136/bmjopen-2021-056973] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
INTRODUCTION Many patients with cancer experience severe psychological distress, but as a result of various barriers, few of them receive psycho-oncological support. E-mental health interventions try to overcome some of these barriers and the limitation of healthcare offers, enabling patients with cancer to better cope with psychological distress. In the proposed trial, we aim to assess the efficacy and cost-effectiveness of the manualised e-mental health intervention Make It Training- Mindfulness-Based and Skills-Based Distress Reduction in Oncology. Make It Training is a self-guided and web-based psycho-oncological intervention, which includes elements of cognitive behavioural therapy, mindfulness-based stress reduction and acceptance and commitment therapy. The training supports the patients over a period of 4 months. We expect the Make It Training to be superior to treatment as usual optimised (TAU-O) in terms of reducing distress after completing the intervention (T1, primary endpoint). METHODS AND ANALYSIS The study comprises a multicentre, prospective, randomised controlled confirmatory interventional trial with two parallel arms. The proposed trial incorporates four distinct measurement time points: the baseline assessment before randomisation, a post-treatment assessment and 3 and 6 month follow-up assessments. We will include patients who have received a cancer diagnosis in the past 12 months, are in a curative treatment setting, are 18-65 years old, have given informed consent and experience high perceived psychological distress (Hospital Anxiety and Depression Scale ≥13) for at least 1 week. Patients will be randomised into two groups (Make It vs TAU-O). The aim is to allocate 600 patients with cancer and include 556 into the intention to treat analysis. The primary endpoint, distress, will be analysed using a baseline-adjusted ANCOVA for distress measurement once the intervention (T1) has been completed, with study arm as a binary factor, baseline as continuous measurement and study centre as an additional categorical covariate. ETHICS AND DISSEMINATION The Ethics Committee of the Medical Faculty Essen has approved the study (21-10076-BO). Results will be published in peer-reviewed journals, conference presentations, the project website, and among self-help organisations. TRIAL REGISTRATION NUMBER German Clinical Trial Register (DRKS); DRKS-ID: DRKS00025213.
Collapse
Affiliation(s)
- Alexander Bäuerle
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital, University of Duisburg-Essen, Essen, Germany
- Comprehensive Cancer Center (CCC), University Hospital Essen, Essen, Germany
| | - Peter Martus
- Institute of Clinical Epidemiology and Applied Biostatistics, Eberhard Karls University Tübingen, University Hospital Tübingen, Tübingen, Germany
| | - Yesim Erim
- Department of Psychosomatic Medicine and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - Caterina Schug
- Department of Psychosomatic Medicine and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany
| | - Jana Heinen
- Department of Psychosomatic Medicine and Psychotherapy, Eberhard Karls University, University Hospital Tübingen, Tübingen, Germany
- Comprehensive Cancer Center (CCC), University Hospital Tübingen, Tübingen-Stuttgart, Germany
| | - Julia Barbara Krakowczyk
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital, University of Duisburg-Essen, Essen, Germany
- Comprehensive Cancer Center (CCC), University Hospital Essen, Essen, Germany
| | - Jasmin Steinbach
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital, University of Duisburg-Essen, Essen, Germany
- Comprehensive Cancer Center (CCC), University Hospital Essen, Essen, Germany
| | - Mirjam Damerau
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital, University of Duisburg-Essen, Essen, Germany
- Comprehensive Cancer Center (CCC), University Hospital Essen, Essen, Germany
| | - Wolfgang Bethge
- Centre of Clinical Trials (ZKS) Tübingen, Eberhard Karls University Tübingen, University Hospital Tübingen, Tübingen, Germany
| | - Andreas Dinkel
- Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, München, Germany
| | - Sebastian Dries
- Healthcare Department, Fraunhofer Institute for Software and Systems Engineering (ISST), Dortmund, Germany
| | - Anja Mehnert-Theuerkauf
- Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Leipzig, Germany
| | - Anja Neumann
- Institute of Health Care Management and Research, University of Duisburg-Essen, Essen, Germany
| | - Dirk Schadendorf
- Comprehensive Cancer Center (CCC), University Hospital Essen, Essen, Germany
- Department of Dermatology, University of Duisburg-Essen, University Hospital Essen, Essen, Germany
| | - Mitra Tewes
- Comprehensive Cancer Center (CCC), University Hospital Essen, Essen, Germany
- Department of Medical Oncology, University of Duisburg-Essen, University Hospital Essen, Essen, Germany
| | - Jörg Wiltink
- Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
| | - Alexander Wünsch
- Clinic for Psychosomatic Medicine and Psychotherapy, Albert-Ludwigs-Universität Freiburg, Freiburg Medical Center, Freiburg, Germany
| | - Stephan Zipfel
- Department of Psychosomatic Medicine and Psychotherapy, Eberhard Karls University, University Hospital Tübingen, Tübingen, Germany
- Comprehensive Cancer Center (CCC), University Hospital Tübingen, Tübingen-Stuttgart, Germany
| | - Johanna Graf
- Department of Psychosomatic Medicine and Psychotherapy, Eberhard Karls University, University Hospital Tübingen, Tübingen, Germany
- Comprehensive Cancer Center (CCC), University Hospital Tübingen, Tübingen-Stuttgart, Germany
| | - Martin Teufel
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital, University of Duisburg-Essen, Essen, Germany
- Comprehensive Cancer Center (CCC), University Hospital Essen, Essen, Germany
| |
Collapse
|
17
|
Kim SH, Choe YH, Cho YU, Park S, Lee MH. Effects of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors: A randomized controlled trial. Psychooncology 2022; 31:460-469. [PMID: 34549864 DOI: 10.1002/pon.5828] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2021] [Revised: 09/04/2021] [Accepted: 09/17/2021] [Indexed: 01/06/2023]
Abstract
OBJECTIVE To examine the effectiveness of partnErship-based, needs-tailored self-Management support Program fOr Women with breast cancER (EMPOWER), a partnership-based, needs-tailored, self-management (SM) support intervention designed to empower post-treatment breast cancer survivors (BCSs) and ultimately improve their health outcomes. METHODS This multi-center, two-armed, randomized controlled trial comprised 94 female BCSs who had completed primary cancer treatment in South Korea. Participants were randomly assigned (1:1) to the intervention group or the wait-list control group. The intervention group received a 7-week EMPOWER intervention via telephone counseling. The primary outcome was empowerment. Secondary outcomes included self-efficacy for post-treatment SM behaviors, mental adjustment, anxiety, depression, and health-related quality of life. Data were collected via a self-reported questionnaire at baseline (T0) and at 8 (T1) and 20 weeks (T2) of follow-up. Linear mixed models were used to assess group differences over time. Effective sizes were calculated using Cohen's d. RESULTS Retention rates were excellent (95.7% at T1; 94.7% at T2). Linear mixed model analyses revealed that the EMPOWER group showed significantly improved empowerment (mean difference 2.24, 95% CI = 0.18 to 4.29; p = 0.016) and general health perception (mean difference 3.68, 95% CI = 0.67 to 6.72; p = 0.037) compared with the control group. Time point analysis showed that several secondary outcomes significantly improved at T1, but the effects were not sustained. CONCLUSION EMPOWER was effective in improving empowerment and general health perception among post-treatment BCS. Further studies are needed to determine the effectiveness of the EMPOWER intervention in other cancer populations.
Collapse
Affiliation(s)
- Soo Hyun Kim
- Department of Nursing, Inha University, Incheon, South Korea
| | - Yu Hyeon Choe
- Department of Nursing, Inha University, Incheon, South Korea
| | - Young Up Cho
- Department of Surgery, Ilsan Cha Hospital, College of Medicine, Cha University, Goyang, South Korea
| | - Seho Park
- Division of Breast Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea
| | - Moon Hee Lee
- Division of Hematology-Oncology, College of Medicine, Inha University, Incheon, South Korea
| |
Collapse
|
18
|
Agbejule OA, Hart NH, Ekberg S, Crichton M, Chan RJ. Self-management support for cancer-related fatigue: a systematic review. Int J Nurs Stud 2022; 129:104206. [DOI: 10.1016/j.ijnurstu.2022.104206] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2021] [Revised: 01/14/2022] [Accepted: 02/10/2022] [Indexed: 11/26/2022]
|
19
|
White V, Linardon J, Stone JE, Holmes-Truscott E, Olive L, Mikocka-Walus A, Hendrieckx C, Evans S, Speight J. Online psychological interventions to reduce symptoms of depression, anxiety, and general distress in those with chronic health conditions: a systematic review and meta-analysis of randomized controlled trials. Psychol Med 2022; 52:548-573. [PMID: 32674747 DOI: 10.1017/s0033291720002251] [Citation(s) in RCA: 30] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND Over the past 15 years, there has been substantial growth in web-based psychological interventions. We summarize evidence regarding the efficacy of web-based self-directed psychological interventions on depressive, anxiety and distress symptoms in people living with a chronic health condition. METHOD We searched Medline, PsycINFO, CINAHL, EMBASE databases and Cochrane Database from 1990 to 1 May 2019. English language papers of randomized controlled trials (usual care or waitlist control) of web-based psychological interventions with a primary or secondary aim to reduce anxiety, depression or distress in adults with a chronic health condition were eligible. Results were assessed using narrative synthases and random-effects meta-analyses. RESULTS In total 70 eligible studies across 17 health conditions [most commonly: cancer (k = 20), chronic pain (k = 9), arthritis (k = 6) and multiple sclerosis (k = 5), diabetes (k = 4), fibromyalgia (k = 4)] were identified. Interventions were based on CBT principles in 46 (66%) studies and 42 (60%) included a facilitator. When combining all chronic health conditions, web-based interventions were more efficacious than control conditions in reducing symptoms of depression g = 0.30 (95% CI 0.22-0.39), anxiety g = 0.19 (95% CI 0.12-0.27), and distress g = 0.36 (95% CI 0.23-0.49). CONCLUSION Evidence regarding effectiveness for specific chronic health conditions was inconsistent. While self-guided online psychological interventions may help to reduce symptoms of anxiety, depression and distress in people with chronic health conditions in general, it is unclear if these interventions are effective for specific health conditions. More high-quality evidence is needed before definite conclusions can be made.
Collapse
Affiliation(s)
- V White
- School of Psychology, Faculty of Health, Deakin University Geelong, Victoria3220, Australia
| | - J Linardon
- School of Psychology, Faculty of Health, Deakin University Geelong, Victoria3220, Australia
| | - J E Stone
- Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria3168, Australia
| | - E Holmes-Truscott
- School of Psychology, Faculty of Health, Deakin University Geelong, Victoria3220, Australia
- The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Victoria3000, Australia
| | - L Olive
- School of Psychology, Faculty of Health, Deakin University Geelong, Victoria3220, Australia
| | - A Mikocka-Walus
- School of Psychology, Faculty of Health, Deakin University Geelong, Victoria3220, Australia
| | - C Hendrieckx
- School of Psychology, Faculty of Health, Deakin University Geelong, Victoria3220, Australia
- The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Victoria3000, Australia
| | - S Evans
- School of Psychology, Faculty of Health, Deakin University Geelong, Victoria3220, Australia
| | - J Speight
- School of Psychology, Faculty of Health, Deakin University Geelong, Victoria3220, Australia
- The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Victoria3000, Australia
| |
Collapse
|
20
|
Heinen J, Bäuerle A, Schug C, Krakowczyk JB, Strunk SE, Wieser A, Beckord J, Jansen C, Dries S, Pantförder M, Erim Y, Zipfel S, Mehnert-Theuerkauf A, Wiltink J, Wünsch A, Dinkel A, Stengel A, Kruse J, Teufel M, Graf J. Mindfulness and skills-based eHealth intervention to reduce distress in cancer-affected patients in the Reduct trial: Intervention protocol of the make it training optimized. Front Psychiatry 2022; 13:1037158. [PMID: 36387004 PMCID: PMC9650647 DOI: 10.3389/fpsyt.2022.1037158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Accepted: 10/12/2022] [Indexed: 11/13/2022] Open
Abstract
INTRODUCTION Cancer-affected patients experience high distress due to various burdens. One way to expand psycho-oncological support is through digital interventions. This protocol describes the development and structure of a web-based psycho-oncological intervention, the Make It Training optimized. This intervention is currently evaluated in the Reduct trial, a multicenter randomized controlled trial. METHODS The Make It Training optimized was developed in six steps: A patient need and demand assessment, development and acceptability analysis of a prototype, the formation of a patient advisory council, the revision of the training, implementation into a web app, and the development of a motivation and evaluation plan. RESULTS Through a process of establishing cancer-affected patients' needs, prototype testing, and patient involvement, the Make It Training optimized was developed by a multidisciplinary team and implemented in a web app. It consists of 16 interactive self-guided modules which can be completed within 16 weeks. DISCUSSION Intervention protocols can increase transparency and increase the likelihood of developing effective web-based interventions. This protocol describes the process and results of developing a patient-oriented intervention. Future research should focus on the further personalization of web-based psycho-oncological interventions and the potential benefits of combining multiple psychotherapeutic approaches.
Collapse
Affiliation(s)
- Jana Heinen
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.,Comprehensive Cancer Center (CCC-TS), University Hospital Tübingen, Tübingen, Germany
| | - Alexander Bäuerle
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Germany.,Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.,Comprehensive Cancer Center, University Hospital Essen, Essen, Germany
| | - Caterina Schug
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Julia Barbara Krakowczyk
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Germany.,Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.,Comprehensive Cancer Center, University Hospital Essen, Essen, Germany
| | - Sven Erik Strunk
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Germany
| | - Alexandra Wieser
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.,Comprehensive Cancer Center (CCC-TS), University Hospital Tübingen, Tübingen, Germany
| | - Jil Beckord
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Germany.,Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.,Comprehensive Cancer Center, University Hospital Essen, Essen, Germany
| | - Christoph Jansen
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Germany.,Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.,Comprehensive Cancer Center, University Hospital Essen, Essen, Germany
| | - Sebastian Dries
- Fraunhofer Institute for Software and Systems Engineering (ISST), Dortmund, Germany
| | - Michael Pantförder
- Fraunhofer Institute for Software and Systems Engineering (ISST), Dortmund, Germany
| | - Yesim Erim
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - Stephan Zipfel
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.,Comprehensive Cancer Center (CCC-TS), University Hospital Tübingen, Tübingen, Germany
| | - Anja Mehnert-Theuerkauf
- Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Leipzig, Germany
| | - Jörg Wiltink
- Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
| | - Alexander Wünsch
- Clinic for Psychosomatic Medicine and Psychotherapy, Freiburg Medical Center, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.,Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Andreas Dinkel
- Department of Psychosomatic Medicine and Psychotherapy, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - Andreas Stengel
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.,Comprehensive Cancer Center (CCC-TS), University Hospital Tübingen, Tübingen, Germany.,Charité Center for Internal Medicine and Dermatology, Department for Psychosomatic Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany
| | - Johannes Kruse
- Department of Psychotherapy and Psychosomatics, Justus Liebig University Giessen, Giessen, Germany.,Department of Psychotherapy and Psychosomatics, Philipps University Marburg, Marburg, Germany
| | - Martin Teufel
- Clinic for Psychosomatic Medicine and Psychotherapy, LVR-University Hospital Essen, University of Duisburg-Essen, Essen, Germany.,Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University of Duisburg-Essen, Essen, Germany.,Comprehensive Cancer Center, University Hospital Essen, Essen, Germany
| | - Johanna Graf
- Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany.,Comprehensive Cancer Center (CCC-TS), University Hospital Tübingen, Tübingen, Germany
| |
Collapse
|
21
|
Li J, Zhu C, Liu C, Su Y, Peng X, Hu X. Effectiveness of eHealth interventions for cancer-related pain, fatigue, and sleep disorders in cancer survivors: A systematic review and meta-analysis of randomized controlled trials. J Nurs Scholarsh 2021; 54:184-190. [PMID: 34791779 DOI: 10.1111/jnu.12729] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2021] [Revised: 09/13/2021] [Accepted: 10/15/2021] [Indexed: 02/05/2023]
Abstract
PURPOSE To systematically evaluate the effects of Electronic health (eHealth) interventions on fatigue, pain, and sleep disorders in cancer survivors. DESIGN A systematic review and meta-analysis was conducted. METHODS Relevant studies were searched from five databases (MEDLINE, Embase, the Cochrane Central Register of Controlled trials, CINAHL, and PsycINFO). The comprehensive literature search was done in December 2020. Only randomized controlled trials (RCTs) that examined the effects of eHealth interventions among cancer survivors were included. FINDINGS Twenty-five RCTs were included. The meta-analysis showed that eHealth interventions had a positive impact on pain interference (SMD = -0.37, 95% CI: -0.54 to -0.20, p = 0.0001) and sleep disorders (SMD = -0.43, 95% CI: -0.77 to -0.08, p = 0.02) but not on pain severity or fatigue in cancer survivors. The sensitivity and subgroup analyses indicated that the pooled results were robust and reliable. CONCLUSION eHealth interventions are effective in improving pain interference and sleep disorders in cancer survivors. Additional high-quality RCTs are needed to test the effectiveness of eHealth interventions on fatigue, pain, and sleep disorders in cancer survivors. CLINICAL RELEVANCE This systematic review and meta-analysis provides evidence to offer effective and sustainable eHealth care for symptom management among cancer survivors.
Collapse
Affiliation(s)
- Juejin Li
- West China School of Nursing, Sichuan University/Department of Nursing, West China Hospital, Sichuan University, Chengdu, PR China
| | - Chuanmei Zhu
- Outpatient Department, West China Hospital, Sichuan University, Chengdu, PR China
| | - Chunhua Liu
- Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, PR China
| | - Yonglin Su
- Department of Rehabilitation/Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, PR China
| | - Xingchen Peng
- Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, PR China
| | - Xiaolin Hu
- West China School of Nursing, Sichuan University/Department of Nursing, West China Hospital, Sichuan University, Chengdu, PR China
| |
Collapse
|
22
|
Eaton LH, Beck SL, Jensen MP. An Audio-Recorded Hypnosis Intervention for Chronic Pain Management in Cancer Survivors: A Randomized Controlled Pilot Study. Int J Clin Exp Hypn 2021; 69:422-440. [PMID: 34309480 PMCID: PMC8458244 DOI: 10.1080/00207144.2021.1951119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
This pilot study evaluated the feasibility, acceptability, and potential efficacy of a 4-week hypnosis audio-recording intervention in cancer survivors with chronic pain. Forty participants were randomly assigned to treatment (n = 21) or wait-list (n = 19) conditions. Pain intensity ratings were lower at Week 4 for both groups. The effect size for pain reduction in the treatment group was d = 0.25 from baseline to 4 weeks, and the interaction effect (Time x Group) was F = .024; η2p = .001. The small interaction effect may be due to the availability of only one recording and large variability in dose. Qualitative data indicated that the intervention's benefits included participation in self-care, improved relaxation, and an opportunity to focus on oneself in a positive way. Further efficacy testing of an audio-recording intervention in a fully powered clinical trial is warranted.
Collapse
Affiliation(s)
- Linda H Eaton
- School of Nursing and Health Studies, University of Washington Bothell, USA
| | - Susan L Beck
- College of Nursing, University of Utah, Salt Lake City, USA
| | - Mark P Jensen
- Department of Rehabilitation Medicine, University of Washington, Seattle, USA
| |
Collapse
|
23
|
Martínez-Miranda P, Casuso-Holgado MJ, Jesús Jiménez-Rejano J. Effect of patient education on quality-of-life, pain and fatigue in breast cancer survivors: A systematic review and meta-analysis. Clin Rehabil 2021; 35:1722-1742. [PMID: 34266300 DOI: 10.1177/02692155211031081] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
OBJECTIVE To synthesise the existing evidence about the effect of patient education, either used alone or as adjunctive therapy, on the improvement of quality of life, pain and fatigue in adult breast cancer survivors. DATA SOURCES We searched PubMed, Web of Science, CINAHL, SCOPUS, Cochrane Plus, PEDro, Dialnet and Clinicaltrials.gov databases. METHODS We conducted this systematic review in accordance with the PRISMA statement. Only randomised controlled trials with adult breast cancer survivors were included. We assessed the methodological quality of the studies using the PEDro scale and the Cochrane risk-of-bias tool. We synthesised evidence using the GRADE tool. RESULTS We included 14 studies (PEDro 4-8 points) comprising 1749 adult women who survived breast cancer, of which we included 12 in the quantitative analysis. There were statistically significant short-term benefits for improved global quality-of-life (standardised mean difference [SMD] = 0.43, P = 0.05, 95% CI [0.00, 0.85]; GRADE: low certainty; not important), emotional quality-of-life (SMD = 0.32, P = 0.04, 95% CI [0.02, 0.62]) and fatigue (SMD = 0.24, P = 0.0004, 95% CI [0.11, 0.37]; GRADE: low certainty; not important). However, there were not statistically significant for pain severity (SMD = -0.05, P = 0.67, 95% CI [-0.26, 0.17]; GRADE: low certainty; not important) and fear to recurrence (SMD = -0.05, P = 0.68, 95% CI [-0.31, 0.20]; GRADE: moderate certainty; not important). CONCLUSION Patient education have a significative effect in short-term global quality-of-life, emotional quality-of-life and fatigue, though all the results were classified as 'not important'.
Collapse
Affiliation(s)
- Patricia Martínez-Miranda
- Department of Physiotherapy, Faculty of Nursing, Physiotherapy and Podiatry, Universidad de Sevilla, Sevilla, Spain
| | - María Jesús Casuso-Holgado
- Department of Physiotherapy, Faculty of Nursing, Physiotherapy and Podiatry, Universidad de Sevilla, Sevilla, Spain
| | - José Jesús Jiménez-Rejano
- Department of Physiotherapy, Faculty of Nursing, Physiotherapy and Podiatry, Universidad de Sevilla, Sevilla, Spain
| |
Collapse
|
24
|
Online interventions aimed at reducing psychological distress in cancer patients: evidence update and suggestions for future directions. Curr Opin Support Palliat Care 2020; 14:27-39. [PMID: 31895066 DOI: 10.1097/spc.0000000000000483] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
PURPOSE OF REVIEW A great proportion of people affected by cancer experience psychological distress. To reduce pressure on limited health-management resources available, evidence-based eHealth or online interventions can fill an important gap by making psychosocial care more easily accessible. However, evidence of their effectiveness is mixed. This present review provides an update on the effectiveness of online interventions in reducing psychological distress in patients with cancer by including studies published from January 2018 to September 2019. RECENT FINDINGS Thirty-three publications describing online interventions were included in the review, including web-based, blended care, telehealth, mHealth, and other online interventions. There was great heterogeneity across studies. The evidence of online interventions' effectiveness in reducing distress was mixed; there was partial support for reduction in psychological distress and depression, but limited evidence for reducing anxiety. Some important limitations should be taken into account when interpreting the results. SUMMARY Online interventions for people affected by cancer, in general, are well received and seem to be a necessary component of comprehensive cancer care. However, these interventions should be more rigorously tested to provide more conclusive evidence about their effectiveness.
Collapse
|
25
|
Manne S, Hudson S, Frederick S, Mitarotondo A, Baredes S, Kalyoussef E, Ohman‐Strickland P, Kashy DA. e‐Health
self‐management intervention for oral and oropharyngeal cancer survivors: design and single‐arm pilot study of empowered survivor. Head Neck 2020; 42:3375-3388. [DOI: 10.1002/hed.26403] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2019] [Revised: 06/23/2020] [Accepted: 07/14/2020] [Indexed: 12/24/2022] Open
Affiliation(s)
- Sharon Manne
- Behavioral Science Rutgers Cancer Institute of New Jersey New Brunswick NJ USA
| | - Shawna Hudson
- Department of Family Medicine Rutgers Cancer Institute of New Jersey New Brunswick NJ USA
| | - Sara Frederick
- Behavioral Science Rutgers Cancer Institute of New Jersey New Brunswick NJ USA
| | - Anna Mitarotondo
- Behavioral Science Rutgers Cancer Institute of New Jersey New Brunswick NJ USA
| | - Soly Baredes
- Otolaryngology Rutgers New Jersey Medical School Newark NJ USA
| | - Evelyne Kalyoussef
- Department of Otolaryngology Rutgers New Jersey Medical School Newark NJ USA
| | - Pamela Ohman‐Strickland
- Department of Biostatistics and Epidemiology Rutgers School of Public Health Piscataway NJ USA
| | - Deborah A. Kashy
- Department of Psychology Michigan State University East Lansing Michigan USA
| |
Collapse
|
26
|
Smith SK, Westbrook K, MacDermott K, Amarasekara S, LeBlanc M, Pan W. Four Conversations: A Randomized Controlled Trial of an Online, Personalized Coping and Decision Aid for Metastatic Breast Cancer Patients. J Palliat Med 2020; 23:353-358. [PMID: 31638448 DOI: 10.1089/jpm.2019.0234] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Background: Anticipating and making health care decisions about appropriate or preferred treatment around end-of-life care are intellectually challenging and emotionally distressing for metastatic breast cancer (MBC) patients, new interventions are needed. Objective: This study examined the effect of Four Conversations, an online and personalized coping and decision aid curriculum, on the completion of advance care directives and shared decision making among patients and their loved ones, clinicians, and spirit. Design: Participants were randomized 1:1 to Four Conversations or wait-listed usual care conditions. Setting: Adult breast cancer survivors with metastatic disease were recruited nationally. Measurements: Electronic surveys collected self-reported demographic, clinical, and outcome data at baseline and four weeks postintervention. Results: Participants (N = 252) were mean age 53.6 ± 11.0 years; 100% female; 88% Caucasian; 67% married; and 33% employed. Over half (54%) of treatment arm participants without an advance directive completed one by study end, most (62%) felt that Four Conversations helped them quite a bit or a great deal in making a better decision, and 90% would recommend to others. Difference in the change in decisional conflict scores for treatment and control conditions was not significant (p = 0.07). Conclusions: These results suggest that Four Conversations facilitated the completion of advance care directives. Given that reductions in decisional conflict scores between the treatment and control arms were not significant, we cannot conclude that program use was associated with improved decisional conflict among MBC survivors. Online programs can be a feasible and effective alternative to in-person support.
Collapse
Affiliation(s)
- Sophia K Smith
- Duke University School of Nursing, Durham, North Carolina
- Cancer Control and Population Sciences, Duke Cancer Institute, Durham, North Carolina
| | - Kelly Westbrook
- Cancer Control and Population Sciences, Duke Cancer Institute, Durham, North Carolina
| | | | | | | | - Wei Pan
- Duke University School of Nursing, Durham, North Carolina
| |
Collapse
|
27
|
Zheng C, Chen X, Weng L, Guo L, Xu H, Lin M, Xue Y, Lin X, Yang A, Yu L, Xue Z, Yang J. Benefits of Mobile Apps for Cancer Pain Management: Systematic Review. JMIR Mhealth Uhealth 2020; 8:e17055. [PMID: 32012088 PMCID: PMC7005688 DOI: 10.2196/17055] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2019] [Revised: 12/11/2019] [Accepted: 12/15/2019] [Indexed: 12/24/2022] Open
Abstract
Background Pain ratings reported by patients with cancer continue to increase, and numerous computer and phone apps for managing cancer-related pain have been developed recently; however, whether these apps effectively alleviate patients’ pain remains unknown. Objective This study aimed to comprehensively evaluate the role of mobile apps in the management of cancer pain. Methods Literature on the use of apps for cancer pain management and interventions, published before August 2019, was retrieved from the following databases: MEDLINE, Embase, Cochrane, CINAHL, Scopus, and PsycINFO. The effects of apps on cancer pain were evaluated using RevMan5.3 software, and the rates of adverse drug reactions were analyzed using the R Statistical Software Package 3.5.3. Results A total of 13 studies were selected for the analysis: 5 randomized controlled trials (RCTs), 4 before-after studies, 2 single-arm trials, 1 prospective cohort study, and 1 prospective descriptive study. The 5 RCTs reported data for 487 patients (240 patients in the intervention group and 247 patients in the control group), and the remaining studies reported data for 428 patients. We conducted a meta-analysis of the RCTs. According to the meta-analysis, apps can significantly reduce pain scores (mean difference [MD]=–0.50, 95% CI –0.94 to –0.07, I2=62%, P=.02). We then used apps that have an instant messaging module for subgroup analysis; these apps significantly reduced patients’ pain scores (MD=–0.67, 95% CI –1.06 to –0.28, I2=57%, P<.01). Patients using apps without an instant messaging module did not see a reduction in the pain score (MD=0.30, 95% CI –1.31 to 1.92, I2=70%, P=.71). Overall, patients were highly satisfied with using apps. Other outcomes, such as pain catastrophizing or quality of life, demonstrated greater improvement in patients using apps with instant messaging modules compared with patients not using an app. Conclusions The use of apps with instant messaging modules is associated with reduced pain scores in patients with cancer-related pain, and patient acceptance of these apps is high. Apps without instant messaging modules are associated with relatively higher pain scores. The presence of an instant messaging module may be a key factor affecting the effect of an app on cancer pain.
Collapse
Affiliation(s)
- Caiyun Zheng
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.,School of Pharmacy, Fujian Medical University, Fuzhou, China
| | - Xu Chen
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China
| | - Lizhu Weng
- Department of Pharmacy, Xiamen Maternity and Child Care Hospital, Xiamen, China
| | - Ling Guo
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China
| | - Haiting Xu
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China
| | - Meimei Lin
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China
| | - Yan Xue
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China
| | - Xiuqin Lin
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China
| | - Aiqin Yang
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China
| | - Lili Yu
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China
| | - Zenggui Xue
- Department of Pharmacy, Fuqing City Hospital, Fuzhou, China
| | - Jing Yang
- School of Pharmacy, Fujian Medical University, Fuzhou, China.,Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, China
| |
Collapse
|
28
|
Xu A, Wang Y, Wu X. Effectiveness of e-health based self-management to improve cancer-related fatigue, self-efficacy and quality of life in cancer patients: Systematic review and meta-analysis. J Adv Nurs 2019; 75:3434-3447. [PMID: 31566769 DOI: 10.1111/jan.14197] [Citation(s) in RCA: 47] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2019] [Revised: 08/20/2019] [Accepted: 09/04/2019] [Indexed: 12/24/2022]
Abstract
AIMS To integrate the overall effect of e-health based self-management on cancer-related fatigue (CRF), self-efficacy, and quality of life (QOL) among adult cancer patients. DESIGN A systematic review and meta-analysis of randomized controlled trials. DATA SOURCES We researched PubMed, Cumulative Index Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials, Web of Science and Embase up to 14 July 2019. REVIEW METHODS We conducted the review with the Cochrane Handbook (version 5.1.0) and measured the quality of evidence with the Grading of Recommendations Assessment, Development and Evaluation criteria. RESULTS Literature searching identified 15 trials with a total of 2,337 participants. Integrated results analysis of e-health based self-management demonstrated a statistically significant but small effect on CRF and self-efficacy, but no statistically significant improvement on the QOL. Meanwhile, subgroup analysis indicated that e-health based self-management had a larger effect on fatigue compared with usual care/waiting list control. CONCLUSION E-health based self-management is effective for CRF and self-efficacy, but not the QOL. More high-quality randomized control trials are warranted to confirm these conclusions. IMPACT Results showed e-health could improve fatigue and self-efficacy but not the QOL. Health providers could take into the various factors of e-health interventions when providing telehealth service. Other researchers might be inspired by the current review before they begin a study about e-health.
Collapse
Affiliation(s)
- Anqi Xu
- School of Nursing, Peking University, Beijing, P.R. China.,Health Science Centre for Evidence-Based Nursing: A Joanna Briggs Institute Centre of Excellence, Peking University, Beijing, P.R. China
| | - Yinping Wang
- School of Public Health, Peking University, Beijing, P.R. China
| | - Xue Wu
- School of Nursing, Peking University, Beijing, P.R. China.,Health Science Centre for Evidence-Based Nursing: A Joanna Briggs Institute Centre of Excellence, Peking University, Beijing, P.R. China
| |
Collapse
|